We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to continue to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases. For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl
View Top Employees from CelgeneWebsite | http://www.bms.com |
Ticker | CELG |
Revenue | $15.28 billion |
Employees | 3,041 (3,041 on RocketReach) |
Founded | 1986 |
Address | 86 Morris Avenue, Summit, New Jersey 07901, US |
Phone | (908) 673-9000 |
Fax | (908) 673-9001 |
Technologies |
JavaScript,
HTML,
Twitter
+355 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Healthcare, Hematology, Pharmaceuticals, Oncology, Biotechnology, Inflammation, Drug Manufacturing & Research, Immunology, Cancer, R&D, Innovation, Immunooncology, Biopharma, Epigenetics, Protein Homeostasis, Translation Medicine, Orphan diseases |
Keywords | Cancer Treatment, Specialty Pharmaceutical, Innovative Medicine, Biopharmaceuticals, Blood Cancer Treatment |
Competitors | Biogen, Genentech, Regeneron, Seagen, bluebird bio |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular Celgene employee's phone or email?
The Celgene annual revenue was $15.28 billion in 2024.
Mark Alles is the Chairman and Chief Executive Officer of Celgene.
3,041 people are employed at Celgene.
Celgene is based in Summit, New Jersey.
The NAICS codes for Celgene are [541, 541713, 54, 54171, 5417].
The SIC codes for Celgene are [873, 87].